Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.58 USD | -1.79% | -4.71% | -16.97% |
05:12pm | Bristol Myers: national schizophrenia campaign | CF |
02:34pm | Bristol-Myers Squibb Says US FDA Reassigns Action Date Subcutaneous Nivolumab | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.97% | 87.9B | |
+37.77% | 705B | |
+32.82% | 583B | |
-3.66% | 364B | |
+20.19% | 332B | |
+4.94% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.80% | 169B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Transcript : Bristol-Myers Squibb Company Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 08